Refresher Courses

RC 316 - Role of imaging in immunotherapy: tumour response assessment and complications

Lectures

1
RC 316 - A. What is immunotherapy and (how) does it work?

RC 316 - A. What is immunotherapy and (how) does it work?

13:47C. Dromain, Lausanne / Switzerland

Learning Objectives
1. To discuss the concept of immunotherapy treatment in cancer.
2. To learn the different types of immunotherapies.
3. To understand the challenges of assessing immunotherapy response.

2
RC 316 - B. Challenges in measuring immunotherapy response

RC 316 - B. Challenges in measuring immunotherapy response

15:12T. Persigehl, Cologne / Germany

Learning Objectives
1. To understand the limitations of RECIST and to become aware of the immune response criteria.
2. To learn about the specifics of immune-related RECIST.
3. To become familiar with pseudoprogression and hyperprogression.

3
RC 316 - C. Functional and molecular imaging: FDG and beyond

RC 316 - C. Functional and molecular imaging: FDG and beyond

16:10V. Goh, London / UK

Learning Objectives
1. To understand the current role of [18F]FDG-PET in immunotherapy response assessment.
2. To become familiar with the concepts of Immuno-PET.
3. To learn the applications of novel Immuno-PET tracers.

4
RC 316 - D. Complications of immunotherapy

RC 316 - D. Complications of immunotherapy

20:06O. Sedlaczek, Heidelberg / Germany

Learning Objectives
1. To learn which immunotherapies frequently lead to complications.
2. To become familiar with which life-threatening complicationscan be caused by immunotherapies.
3. To learn when immunotherapy-related complications commonly occur.

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.